Gene Expression Reagents Market: Growth and Sales Forecast 2013 - 2019
Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/gene-expression-reagents.html
There is a possibility of the alteration of several steps in gene expression process such as in RNA splicing, post-translational modification of proteins and others. Gene regulation is the basis for morphogenesis, cellular differentiation and versatility and renders cell control over structure and function of the genes. Gene expression profiling refers to the process of measuring the activity (expression) of several genes at once in to understand the cellular functions. This analysis can facilitate scientists to identify the molecular basis of phenotypic differences and also enables selection of gene expression targets for the future research studies.
The various analysis techniques employed for gene expression are SAGE (serial analysis of gene expression), Real Time PCR-based gene expression profiling, microarray analysis, transcriptome sequencing and others. Gene expression reagents are the chemicals used in gene expression studies performed to determine the gene expression patterns. Sample preparation and isolation kits, sample labeling and amplification kits, TaqMan Gene Expression assay kits, gene expression hybridization kits and others are some of the examples of the commercially available gene expression reagents kits. Confirmation of appropriate gene expression is essential in order to ensure normal functioning of genes and any deviation from the normal expression pattern might result in the development of some disorder either genetic or acquired. Also, regulation of faulty gene expression inhibits the production of faulty functional products. For example, in case of cancer patients, RNA silencing is employed that includes the silencing of the cancerous gene expression.
Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2379
The market for gene expression reagents can be analyzed on the basis of the reagents used in gene expression profiling along with application areas and geography. The reagents can be further segmented into the reagents used in PCR, Microarray, SAGE and others. The application areas that can be covered are drug discovery and research, biomarkers identification, clinical diagnostics and others. Geographically the market can be analyzed on the basis of four major regions namely North America, Asia-Pacific, Europe and RoW.
The major factors favoring the growth of the market are consistent technological advances, increased intensity of research and development activities and development of gene expression databases across the globe. In addition, increased investments and funding by the government for genetic research along with elevated awareness levels further propel the market growth. On the other hand, high instrumentation costs along with lack of technical expertise in this field would impede the growth of the market. Owing to several advantages and increasing preference for personalized medicine, the scope for growth and uptake of gene expression studies will also increase and in turn increase uptake of gene expression reagents. Affymetrix, Inc., Illumina, Inc., Qiagen N.V., Thermo Fisher Scientific (Life Technologies Corporation), Bio-Rad Laboratories, Inc. and Agilent Technologies are some of the companies competing in gene expression reagents market.
Request Table of Content of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2379
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Transparency Market Research,
90 State Street,
Albany NY – 12207
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene Expression Reagents Market: Growth and Sales Forecast 2013 - 2019 here
News-ID: 976266 • Views: 97
More Releases from Transparency Market Research
Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the
More Releases for RNA
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
Automated DNA/RNA Isolation System Market Overview Till 2018-2023
Future Market Reports on Global Automated DNA/RNA Isolation System 2018 Research Report presents a professional and complete analysis of on the current Industry situation. The Global report includes Automated DNA/RNA Isolation System Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Automated DNA/RNA Isolation System market players and the future prospects from various angles
RNA Sequencing: Technologies and Analyses of Global Market Trends
"The Latest Research Report RNA Sequencing: Technologies and Global Markets provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" The global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate (CAGR) of 14.9%. The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8
Topics Presented this February 2018 at RNA Therapeutics
SMi’s RNA Therapeutics will be bringing a global presence from MHRA, The RNA Institute, MiNA Therapeutics, AstraZeneca R&D, GSK, Sanofi, CureVac and more. With an agenda full of exciting and new approaches, examine the latest developments in delivery systems for RNA Therapeutics, including Exosomes, Nanocomplexes and Platform Delivery Approaches and patenting RNA Therapeutics. www.therapeutics-rna.com/opr Spotlight: Want to learn about exploiting exosomes for therapeutic use in patients with cystic fibrosis? Have questions answered during
RNA Analysis Market worth 3.62 billion USD by 2021
RNA Analysis Market size was around USD 1.89 billion in 2016. It is expected to grow at a CAGR of 13.9% to reach USD 3.62 billion by 2021. The market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines. However, lack of skilled professionals in the transcriptomics field and lack
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led